World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
137
Citations
99230
World Ranking
1862
National Ranking
1058

Overview

Dennis D. Weisenburger is affiliated with the University of Nebraska Medical Center in the United States. Their primary research focus lies within the field of Medicine, with specific expertise spanning pathology and forensic medicine, oncology, genetics, immunology, and molecular biology. The bulk of their publications contribute to understanding lymphoma diagnosis and treatment as well as related hematological malignancies.

The scientist has contributed notably to the areas of lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, viral-associated cancers and disorders, CAR-T cell therapy research, T-cell and retrovirus studies, immune cell function and interaction, and cutaneous lymphoproliferative disorders research.

They have published several papers, including recent works such as:

  • A Review and Update with Perspective of Evidence that the Herbicide Glyphosate (Roundup) is a Cause of Non-Hodgkin Lymphoma (2021), published in Clinical Lymphoma Myeloma & Leukemia
  • DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS (2022), published in Blood
  • Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP (2021), published in Clinical Cancer Research
  • Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice (2022), published in Journal of Clinical Oncology
  • Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma (2021), published in Clinical Cancer Research

Frequent collaborators in their research include Joo Y. Song, Wing C. Chan, Timothy C. Greiner, Javeed Iqbal, and Elaine S. Jaffe. These partnerships highlight a consistent engagement with experts across hematology and oncology research fields.

The scientist has published extensively in several notable venues, with frequent publications in:

  • Blood
  • Hematological Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Clinical Cancer Research
  • Journal of Clinical Oncology

Their research output emphasizes molecular and clinical aspects of lymphoma and related hematological diseases, contributing important insights into disease mechanisms, diagnostics, and potential therapeutic strategies. Their work integrates diverse biomedical disciplines, supporting the advancement of knowledge in oncology and hematopathology.

Best Publications

  • Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

    Ash A. Alizadeh;Michael B. Eisen;R. Eric Davis;Izidore S. Lossos

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

    James O. Armitage

  • International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

    Julie M. Vose;M. Neumann;Mildred E. Harris

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

    Lindsay M. Morton;Sophia S. Wang;Sophia S. Wang;Susan S. Devesa;Susan S. Devesa;Patricia Hartge;Patricia Hartge

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

    James O. Armitage;Dennis D. Weisenburger

  • Oncogenically active MYD88 mutations in human lymphoma

    Vu N. Ngo;Vu N. Ngo;Ryan M. Young;Roland Schmitz;Sameer Jhavar

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

    Christian Steidl;Tang Lee;Sohrab P. Shah;Pedro Farinha

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

    Georg Lenz;George W. Wright;N. C.Tolga Emre;Holger Kohlhammer

  • ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project

    Kerry J. Savage;Nancy Lee Harris;Julie Marie Vose;Fred Ullrich

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    Nathalie A. Johnson;Graham W. Slack;Kerry J. Savage;Joseph M. Connors

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations

    J. R. Anderson;J. O. Armitage;D. D. Weisenburger

Frequent Co-Authors

James O. Armitage
James O. Armitage University of Nebraska Medical Center
Julie M. Vose
Julie M. Vose University of Nebraska Medical Center
Wing C. Chan
Wing C. Chan City of Hope
Jan Delabie
Jan Delabie University Health Network
Warren G. Sanger
Warren G. Sanger University of Nebraska Medical Center
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Elias Campo
Elias Campo University of Barcelona
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Andreas Rosenwald
Andreas Rosenwald University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medical careers in the USA are highly diverse, and students often explore related online degrees that can complement or offer alternative pathways to traditional medicine. Many choose management roles, finding that a healthcare administration accelerated degree can quickly prepare them for leadership positions in hospitals and healthcare organizations.

For nurses aiming to advance their clinical expertise, programs like adn to np bridge programs provide a flexible way to upgrade their credentials online, opening doors to higher responsibilities and better pay.

Nutrition is another popular field. Earning an online dietitian degree can lead to careers in dietary consulting, wellness coaching, or clinical nutrition.

Those interested in high-quality healthcare management programs should look for cahme-accredited master's degrees, which are recognized for meeting rigorous industry standards.

Best Scientists Citing Dennis D. Weisenburger

Trending Scientists

Recently Published Articles